A New Look at the Need for Chemotherapy in Common Form of Breast Cancer
A study just published in the New England Journal of Medicineexploring a gene test suggests that chemotherapy may be avoided for more than two-thirds of women with the most common type of breast cancer. Rutgers Cancer Institute of New Jersey Chief Medical OfficerDeborah Toppmeyer, MD, who is the director of both the Stacy Goldstein Breast Cancer Center and LIFE Center at Rutgers Cancer Institute and a professor of medicine at Rutgers Robert Wood Johnson Medical School, is among the study collaborators. The research was led by the ECOG-ACRIN Cancer Research Group and presented at the recent American Society of Clinical Oncology Annual Meeting.